A review is given of 457 episodes of atrialfibrillation that occurred in 318 patients and were treated by DC shock. Antidysrhythmic drugs, such as quinidine, procainamide, and propranolol, given singly or in combination, were used concomitantly in 389 instances, and DC shock alone was given in 68 instances. The combined effects of quinidine and DC shock, and of procainamide and DC shock were studied in the experimental animal.
In a previous paper (Szekely et al., I969) we reported on the effects of the concomitant use of digitalis and direct current (DC) shock, and presented clinical and experimental evidence, in agreement with others (Lown, Kleiger, and Williams, I965; Kleiger and Lown, I966; Oram, I967) , that DC shock potentiates the cardiotoxicity of digitalis. In the present communication, our aim is to evaluate clinical and experimental observations on the concomitant use of various antidysrhythmic drugs and DC shock.
Method, clinical groups, and experimental material (A) Clinical Five hundred and fifty consecutive episodes of ectopic tachycardia treated by DC shock have been reviewed. Of these, a total of 457 episodes of atrial fibrillation occurring in 3I8 patients form the basis of the present observations. 24I patients had rheumatic heart disease, 30 had coronary heart disease with or without hypertension, 4 had congenital heart disease, ii had thyrotoxicosis, I had chronic pulmonary heart disease, and there were 31 patients with no firm clinical diagnosis, and a number of these were Received 14 July I969.
suspected to have cardiomyopathy. In 389 instances digitalis, quinidine, procainamide, and propranolol were used singly or in combination at the time of DC shock therapy, and in the remaining 68 instances no antidysrhythmic drugs were used at all. The method of DC shock treatment was the same as described before (Szekely, Batson, and Stark, I966; Szekely et al., I969) .
(B) Experimental A total of 30 experiments was carried out in cats weighing between I4 and 3.5 kg. The animals were anaesthetized with intraperitoneal sodium pentobarbitone, 45-50 mg./kg. The trachea was cannulated, and artificial ventilation was given intermittently with a respiratory pump. The arterial blood pressure was continuously recorded by a mercury manometer which was attached to the carotid artery. A standard lead II or occasionally lead III electrocardiogram was recorded throughout the experiment. Quinidine and procainamide were given by injection into the femoral vein. DC shocks were delivered at an energy level setting of 40 to 6o joules.
Clinical observations
The 457 episodes of atrial fibrillation treated by DC shock were divided into several group.bmj.com on June 22, 2017 -Published by http://heart.bmj.com/ Downloaded from 2io Szekely, Wynne, Pearson, Batson, and Sideris (Fig. i) . The serum transaminase level was raised to 85 units/ml. Quinidine was discontinued and propranolol substituted. The patient made a good recovery and she is still in sinus rhythm I2 months after the episode.
Quinidine and propranolol In I3 instances in 9 patients quinidine sulphate 800 mg. daily and propranolol 30 to 6o mg. daily were used '3 to 5 days before elective electroconversion (Table 2) . Sinus rhythm was restored in all 13 cases. The average serum quinidine level was 3.5 mg./I. The average energy necessary for conversion was I50 joules. Atrial extrasystoles were observed immediately after conversion in I5 per cent, nodal rhythm in 7.5 per cent, and ventricular extrasystoles in 7-5 per cent of the cases. In this group, serum potassium levels ranged from 3-8 to 4-8 mEq/l., averaging 4-2 mEq/l. On 2 occasions, the heart rate immediately after DC shock was unduly slow for a few seconds, suggesting sino-atrial node depression.
Procainamide Included in this group are I92 episodes of atrial fibrillation occurring in I71 patients. The patients received procainamide, 3 g. daily, 3 to 5 days before electroconversion. On II5 occasions the patients continued on a maintenance dose of digitalis and on 77 occasions digitalis was discontinued 3 to 5 days before electroconversion, or not used at all (Table 2) . Sinus rhythm was restored in the two groups in 84 and 80 per cent of the cases, respectively. The average energy necessary to restore sinus rhythm was I25 joules. The over-all incidence of atrial extrasystoles was ii per cent, of atrial tachycardia 9.5 per cent, of nodal rhythm 7 per cent, of ventricular extrasystoles 23 per cent, and of ventricular tachycardia 6 per cent. There were 3 episodes of partial AV block (I *5 %), lasting a few seconds, 30 minutes, and 3 hours, respectively. Here again, the incidence of post-shock dysrhythmias was higher when digitalis was given as well, as seen in Table 2 . Serum potassium levels ranged from 3-8 to 4.4 mEq/l., averaging 3.9 mEq/l. in the digitalis group, and 4-0 mEq/l. in the non-digitalis group.
Procainamide and propranolol There were 77 patients who received on 9I occasions 2 g. procainanide and 30 to 8o mg. propranolol daily for 3 to 5 days before electroconversion. On 6o occasions the patients continued with a maintenance dose of digoxin, and on 3I occasions digitalis was discontinued 3 tO 5 days before electroconversion. The results are shown in Table 2 . Sinus rhythm was restored in 95 and 87 per cent of the cases, respectively. The average energy necessary for conversion was i i5 joules. Of the various post-shock dysrhythmias, atrial extrasystoles occurred in IO per cent of the cases, atrial tachycardia in 5.5 per cent, nodal rhythm in 5-5 per cent, ventricular extrasystoles in 14 per cent, and ventricular tachycardia in 6-5 per cent of the cases. There was i transient episode of partial AV block, and 2 episodes which were considered to represent sino-atrial block. When the patients were divided into 2 groups, namely those who had digitalis as well, and those in whom digitalis was discontinued or not used at all before electroconversion, the incidence of post-shock dysrhythmias was higher in the former group. Serum potassium levels were between 3.5 and 4.4 mEq/l., with an average of 4-0 mEq/l. in both digitalis and non-digitalis groups.
Propranolol Ten patients received propranolol, 6o to 80 mg. daily, for 5 days before electroconversion (Table 2) . Sinus rhythm was restored in go per cent of the patients. In I4 out of 20 experiments the combined use of quinidine and DC shock resulted in progressive widening of the QRS complex and/or partial or complete heart block. In 6 of these 14 experiments, DC shock did not increase or alter in any way the quinidineinduced intraventricular or atrioventricular conduction disorder. In 8 experiments, however, the immediate post-shock electrocardiograms frequently showed further transient or persisting widening of the QRS complex or increase in the AV block, as compared with the immediate pre-shock electrocardiograms. Illustrative tracings are shown in Fig. 2 and 3 . In the other 6 experiments the administration of quinidine and DC shock resulted in ectopic impulse production: ventricular tachycardia on 4 occasions, ventricular fibrillation on i occasion, and ventricular extrasystoles on i occasion. In 3 of these 6 experiments the initial DC shock before the first quinidine injection resulted in conspicuous ST segment depression, T wave inversion, and ST segment elevation, respectively. An illustrative tracing is shown in Fig. 4 In 6 further experiments the administration of a single dose of digoxin 0o25 mg., either early and simultaneously with a quinidine injection or later at the stage of quinidine-induced depression of intraventricular conduction, followed by a DC shock, resulted in transient or persistent ectopic tachycardia on 4 occasions, ventricular fibrillation on i occasion, and no change in the quinidine-induced electrocardiographic pattern on I occasion. In 2 of this special group of 6 experiments, further DC shocks were given during the stage of ectopic tachycardia, but the ectopic rhythm was not abolished (Fig. 5 ).
Procainamide Four experiments were carried out in this group. Amounts of IO tO 20 mg./kg. procainamide per dose were injected intravenously and each injection was followed by a DC shock. The procedure was exactly the same as for quinidine. The combined use of procainamide and DC shock resulted in progressive intraventricular and AV conduction defect in all 4 experiments (Fig. 6) . In 3 experiments, several immediate post-shock electrocardiograms showed potentiation of the procainamide-induced depression of atrioventricular and intraventricular conduction, and in i experiment DC shocks did not increase the procainamide-induced changes.
Discussion
Antidysrhythmic drugs have been used in conjunction with DC shock in an attempt to increase the conversion rate and to prevent early recurrence of the ectopic rhythm. Rossi and Lown (I967) advocated the use of quinidine before electroconversion, being of the opinion that patients receiving quinidine required fewer shocks and lower energy levels to restore sinus rhythm. They also stated that pretreatment with quinidine reduced the incidence of post-shock dysrhythmias and prevented prompt relapse of atrial fibrillation. Hall and Wood (I968) also found that premedication with quinidine reduced the frequency of post-conversion dysrhythmias.
In our whole series of 457 episodes of atrial fibrillation, sinus rhythm was restored by DC shock in 85 per cent of the cases. The conversion rate was 78 per cent in the group of patients not receiving any drugs at all. It was higher in those receiving concomitantly various antidysrhythmic drugs, with a significant increase (92%) in the combined procainamide and propranolol group (p <o.oi). This latter group and the group of patients not treated concomitantly with drugs were comparable regarding the underlying pathology, especially lone atrial fibrillation which accounted for I3 per cent of all episodes treated in both groups. This is relevant, for, in agreement with the observations of Oram and Davies (I964) ., /' version rate was in our experience significantly lower in lone atrial fibrillation than when atrial fibrillation had a detectable underlying cause, 60 per cent and 87-5 per cent, respectively (p <oooi). Addition of propranolol to quinidine also resulted in a very much higher than average conversion rate, but the numbers in this group were too small to establish a statistically significant advantage. However, this small group contained no patients with lone atrial fibrillation, and this undoubtedly contributed to the high success rate. When quinidine alone was used as pretreatment, the conversion rate was higher than when procainamnide alone was given, 88 per cent and 82 per cent, respectively, but this difference is statistically not significant.
Antidysrhythmic drugs did not reduce the energy requirements necessary for the restoration of sinus rhythm.
In the rheumatic group, which is far the largest, representing 75 per cent of all patients and 78 per cent of all episodes included, the conversion rate was 87 per cent in the combined pre-surgical and nonsurgical group, and 89 per cent in the postsurgical group, a difference that is statistically not significant.
We reported previously that the duration of atrial fibrillation was an important factor in influencing the conversion rate, being 98 per cent in those with less than i year duration and 82 per cent in those with more than i year duration (Szekely et al., I966) . This trend has remained unchanged. In the present series, the patients in the various groups were comparable with regard to the duration of atrial fibrillation.
In our experience, the concomitant use of antidysrhythmic drugs did not result on the whole in a reduction of post-shock dysrhythmias. Having regard to the importance of digitalis in causing post-shock dysrhythmias (Szekely et al., I969) , we compared the incidence of post-shock dysrhythmias in patients who received quinidine or procainamide and/or propranolol but no digitalis with that in patients who received no drugs at all, and found that post-shock dysrhythmias were even more frequent in the drugtreated groups of patients. However, when digitalis was continued, the combined use of procainamide and propranolol resulted in a significant decrease in the incidence of postshock atrial tachycardia and ventricular extrasystoles, as compared with the use of procainamide or quinidine alone (p <ooi). This was especially the case when larger doses of propranolol, 8o mg. daily, were used. pranolol, when given in larger than betablocking doses, abolished both digitalisinduced dysrhythmias and digitalis-induced sensitization to electrical shock.
Our experimental findings also suggest that quinidine has no protective action against digitalis and DC shock-induced ectopic tachycardia; in fact, quinidine even tended to reduce digitalis tolerance. This observation is in agreement with that previously reported by Rodensky, Kathe, and Wasserman (I960) .
At the time of DC shock treatment, no patient had significant hypopotassaemia. Hypopotassaemia is an important factor in the development of post-shock dysrhythmias, as pointed out before by Lown and Wittenberg (I968) and Thind, Blakemore, and Zinsser (I969), but in our experience digitalis caused post-shock dysrhythmias even when the serum potassium levels were normal. DC shock per se can cause myocardial potassium loss, as has been shown recently in animal experiments (Regan et al., I969) .
It seems from our clinical and experimental observations that DC shock can increase the cardiotoxicity not only of digitalis, as previously shown (Szekely et The cardiotoxicity of procainamide is perhaps less severe than that of quinidine. In our experience, it caused no serious sideeffects. However, Castellanos and Salhanick (I967) observed conspicuous sino-atrial node depression following the combined use of procainamide and DC shock.
Propranolol, when given in larger doses (6o to 80 mg. daily), alone or added to quinidine or procainamide, resulted in post-shock depression of the sino-atrial node in a few cases. Lown (I968) previously reported sino-atrial standstill and cardiac arrest after the combined use of propranolol and DC shock.
Though currently used antidysrhythmic drugs, given singly or in combination in conjunction with DC shock, can increase the conversion rate of atrial fibrillation, they should be used with great caution, if at all, as their cardiotoxicity may be enhanced by DC shock. Lown (I967) has also stated recently that the major hazard of DC shock treatment is related to the use of digitalis being partly responsible for the immediate post-shock dysrhythmias, and of quinidine causing delayed disorders of the cardiac De sook 60 Aou2e
